Suppr超能文献

肠道微生物群能否解释东西方肝病流行病学的差异?

Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West?

作者信息

Nakamoto Nobuhiro, Schnabl Bernd

机构信息

Department of Medicine, Keio University, Tokyo, Japan.

Department of Medicine, University of California, San Diego, La Jolla, Calif., USA; Department of Medicine, VA San Diego Healthcare System, San Diego, Calif., USA.

出版信息

Inflamm Intest Dis. 2016 Apr;1(1):3-8. doi: 10.1159/000443196. Epub 2016 Jan 20.

Abstract

Changes in bacterial communities are associated with the pathogenesis of many diseases including inflammatory bowel disease and liver disease. Dysbiosis can induce intestinal inflammation resulting in increased intestinal permeability and bacterial translocation. The majority of chronic liver diseases are associated with bacterial translocation resulting in or enhancing an inflammatory response in the liver. Intestinal inflammation and a dysfunctional intestinal barrier are not sufficient to cause liver disease in the absence of an additional liver insult. In this article, the authors summarize differences in intestinal microbiota composition between Eastern and Western countries. The authors specifically discuss whether differences in microbiota composition could explain the epidemiological differences in liver disease found in Asia and Europe/the USA.

摘要

细菌群落的变化与包括炎症性肠病和肝病在内的许多疾病的发病机制相关。生态失调可诱发肠道炎症,导致肠道通透性增加和细菌易位。大多数慢性肝病与细菌易位相关,从而导致或增强肝脏中的炎症反应。在没有额外肝脏损伤的情况下,肠道炎症和功能失调的肠道屏障不足以引发肝病。在本文中,作者总结了东西方国家肠道微生物群组成的差异。作者特别讨论了微生物群组成的差异是否可以解释在亚洲和欧洲/美国发现的肝病流行病学差异。

相似文献

1
Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West?
Inflamm Intest Dis. 2016 Apr;1(1):3-8. doi: 10.1159/000443196. Epub 2016 Jan 20.
2
Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease.
Clin Exp Hepatol. 2019 Mar;5(1):1-10. doi: 10.5114/ceh.2019.83151. Epub 2019 Feb 20.
3
Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
Expert Rev Gastroenterol Hepatol. 2015;9(8):1069-76. doi: 10.1586/17474124.2015.1057122. Epub 2015 Jun 18.
4
Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease.
World J Gastroenterol. 2017 Jun 14;23(22):3954-3963. doi: 10.3748/wjg.v23.i22.3954.
5
Obesity, fatty liver disease and intestinal microbiota.
World J Gastroenterol. 2014 Nov 28;20(44):16452-63. doi: 10.3748/wjg.v20.i44.16452.
6
Intestinal microbiota and nonalcoholic steatohepatitis.
Curr Opin Gastroenterol. 2017 May;33(3):128-133. doi: 10.1097/MOG.0000000000000349.
8
Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease.
World J Hepatol. 2015 Mar 27;7(3):559-65. doi: 10.4254/wjh.v7.i3.559.
9
Alcoholic liver disease: the gut microbiome and liver cross talk.
Alcohol Clin Exp Res. 2015 May;39(5):763-75. doi: 10.1111/acer.12704.
10
Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease.
Aliment Pharmacol Ther. 2015 Nov;42(9):1051-63. doi: 10.1111/apt.13376. Epub 2015 Aug 24.

引用本文的文献

2
: Why Do We Need Another Gastroenterology Journal?
Inflamm Intest Dis. 2016 Apr;1(1):1-2. doi: 10.1159/000445258. Epub 2016 Apr 2.
3
Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.
World J Gastroenterol. 2017 Dec 21;23(47):8355-8366. doi: 10.3748/wjg.v23.i47.8355.

本文引用的文献

2
Subsistence strategies in traditional societies distinguish gut microbiomes.
Nat Commun. 2015 Mar 25;6:6505. doi: 10.1038/ncomms7505.
3
Non-alcoholic Fatty Liver Disease: East Versus West.
J Clin Exp Hepatol. 2012 Jun;2(2):122-34. doi: 10.1016/S0973-6883(12)60101-7. Epub 2012 Jul 21.
4
Epidemiology and risk factors for IBD.
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):205-17. doi: 10.1038/nrgastro.2015.34. Epub 2015 Mar 3.
5
Diversity in gut bacterial community of school-age children in Asia.
Sci Rep. 2015 Feb 23;5:8397. doi: 10.1038/srep08397.
6
Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.
FASEB J. 2015 Mar;29(3):1043-55. doi: 10.1096/fj.14-259515. Epub 2014 Dec 2.
8
Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.
Gastroenterology. 2015 Jan;148(1):203-214.e16. doi: 10.1053/j.gastro.2014.09.014. Epub 2014 Sep 16.
9
Diet and host-microbial crosstalk in postnatal intestinal immune homeostasis.
Nat Rev Gastroenterol Hepatol. 2015 Jan;12(1):14-25. doi: 10.1038/nrgastro.2014.153. Epub 2014 Sep 9.
10
HIV enteropathy and aging: gastrointestinal immunity, mucosal epithelial barrier, and microbial translocation.
Curr Opin HIV AIDS. 2014 Jul;9(4):309-16. doi: 10.1097/COH.0000000000000066.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验